Results

eNauka >  Results >  Early symptomatic improvement with obefazimod in patients with moderately to severely active ulcerative colitis: pooled results from the ABTECT-1 and ABTECT-2 Phase 3, double-blind, placebo-controlled induction trials
Title: Early symptomatic improvement with obefazimod in patients with moderately to severely active ulcerative colitis: pooled results from the ABTECT-1 and ABTECT-2 Phase 3, double-blind, placebo-controlled induction trials
Authors: Armuzzi, A; Atreya, R; Sparrow, MP; Markovic, S; Le, Berre C; Hlavaty, T; Treton, X; Cataldi, F; Jacobstein, D; Rabbat, C;
Shan, K; Dubinsky, MC;
Issue Date: 2026
Publication: JOURNAL OF CROHNS & COLITIS
ISSN: 1873-9946 Journal of Crohn#s and Colitis Search Idenfier
Type: Conference Paper
Collation: vol. 20 br. Supplement_1
DOI: 10.1093/ecco-jcc/jjaf231.1104
WoS-ID: 001666495500001
URI: https://enauka.gov.rs/handle/123456789/1027569
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

Altmetric
Dimensions
Unpaywall

Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.